Lupin Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by MR. NILESH D. GUPTA, was filed 24 Aug 2021.
Lupin Limited: what insiders have been doing
Lupin Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). Nothing new has been filed by managers of Lupin Limited in twelve months, the latest record being from 8 September 2021.
Looking back to 2021, when coverage begins, insiders filed 2 purchases and 21 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Since the insiders bought
- -29.3%Entry ₹940.80 · Close at T+365 ₹664.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Lupin Limited Hold (neutral), based on 36 analysts. Average price target: ₹2,446.14.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 15,000 shares@ ₹985.0021.1% of flowEquity SharesSEBI:63328790a262cb88a3f4fff1f52f4525ea7eac76
- 5,300 sharesEquity SharesSEBI:fcc2c992c335b175f2c327f8d384d697ee8b57a5
- 2,650 sharesEquity SharesSEBI:3027fee388fcb4d020c94a53f424050629ce7f4c
- 2,650 sharesEquity SharesSEBI:f1e77f6a1323494124a2883f9ae02e678f278dc9
- 5,300 shares@ ₹943.5867.3% of flowEquity SharesSEBI:dcf23d3303a7faf0688746f288bcad27229ff339Canonical exit: 18 Nov 2021 (T+90)
- 20,000 shares@ ₹974.000.0023% mcap70.7% of flowEquity SharesSEBI:6573c8eab9f561a1e6980021ec48b35019b4bbaf
- 10,000 shares@ ₹978.000.0011% mcap100.0% of flowEquity SharesSEBI:9d9ae3d69d477b3f73b6b11df3b38cef579185c4
- 2,140 sharesEquity SharesSEBI:48bc42283c768356b4154a09f10888d91c909f03
- 2,140 sharesEquity SharesSEBI:8d6a902dbedb11d82e767d613681c5ca99e13d33
- 3,000 shares@ ₹1,158.30330.0004% mcap58.9% of flowEquity SharesSEBI:4d5446673efa642dc42e78e7a9802bd9781b2670
- 3,000 shares@ ₹1,163.050.0004% mcap46.9% of flowEquity SharesSEBI:536603d1f16e945393f95e4e07d8487f8328ea5d
- 2,000 shares@ ₹1,161.000.0003% mcap8.3% of flowEquity SharesSEBI:bc0c55c67ca1fae9d6d28e7a4b0b7880544a06f9
- 2,140 shares@ ₹1,160.588832.7% of flowEquity SharesSEBI:11caad5df8a084889f02023972d8aa8d28555bf0Canonical exit: 26 Sept 2021 (T+90)
- 20,000 shares@ ₹701.20100.0% of flowEquity SharesSEBI:21d4c9661dc2d9a93812ef19b7e99cfd8cd33c1c
- 50,000 shares@ ₹415.7329.1% of flowEquity SharesSEBI:6c73a11c37ac6dc77ce86b127990548944a4d9d6
- 1,000 shares@ ₹1,126.6510.0001% mcap43.8% of flowEquity SharesSEBI:2ec87c88129f803f53486a652c34b21f79b7ef25
- 500 shares@ ₹1,150.150.0001% mcap7.7% of flowEquity SharesSEBI:34866e1b6aa48789e221c3b96c78bcd27ca5622f
- 1,225 shares@ ₹1,123.13220.0002% mcap100.0% of flowEquity SharesSEBI:bb00afd2edc369b4bc7802b266944fd114ddd5d9
- 500 shares@ ₹1,177.810.0001% mcap8.0% of flowEquity SharesSEBI:4e41850799b480243ef4a7e0130bf5606022d551
- 1,255 shares@ ₹1,152.44380.0002% mcap56.2% of flowEquity SharesSEBI:aafa38a5f7e12f143c071bc361ad35b004eb3cc8
- 900 shares@ ₹1,246.000.0001% mcap100.0% of flowEquity SharesSEBI:d7b8c6267d846d468f7eab92b1d0ff1842c24df7
- 1,000 shares@ ₹1,235.000.0001% mcap100.0% of flowEquity SharesSEBI:7f5d411b1eb8f4ec83fcc774aeb058dde7cbc7e9
- 1,100 shares@ ₹1,232.29550.0002% mcap18.1% of flowEquity SharesSEBI:47641dbe0cbd1769346e2bf1b805e396755e4ca1
- 2,000 shares@ ₹1,214.26350.0003% mcap41.1% of flowEquity SharesSEBI:5e75ee5d94db40c5c4a99fed1816614bab23d412
- 200 shares@ ₹1,208.900.0000% mcap3.2% of flowEquity SharesSEBI:8cff36e0bc543e11f0cb47729a597198d92c005c
25 of 30 declarations
About Lupin Limited
Lupin Limited is an Indian pharmaceutical company focused on the research, development, and manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
